Advertisement

Anticoagulation and Regional Anesthesia Concerns

  • Alan David Kaye
  • Thomas Ngo Trang
  • Elyse M. Cornett
  • Ken Philip EhrhardtJr
  • Rinoo Vasant Shah
Chapter

Abstract

Interventional pain management is an emerging specialty that focuses on the use of procedures to diagnose and to treat chronic pain. Most of these procedures are performed percutaneously and carry a potential risk of bleeding (Manchikanti et al., Pain Physician. 16(2 Suppl):SE261–318, 2013). Regional anesthesia similarly uses percutaneous injection techniques for surgery, perioperatively, and postoperative analgesia. Patients undergoing these treatments may be receiving exogenous anticoagulants or have impaired hemostasis. Clinicians must be aware of best practice guidelines to ensure safety for those patients undergoing these procedures who are taking anticoagulant agents or have impaired hemostasis.

Keywords

Anticoagulation Regional anesthesia Pain management Interventional pain management Coagulation Anticoagulants 

References

  1. 1.
    Manchikanti L, Falco FJ, Benyamin RM, Caraway DL, Kaye AD, Helm S 2nd, Wargo BW, Hansen H, Parr AT, Singh V, Swicegood JR, Smith HS, Schultz DM, Malla Y, Hirsch JA. Assessment of bleeding risk of interventional techniques: a best evidence synthesis of practice patterns and perioperative management of anticoagulant and antithrombotic therapy. Pain Physician. 2013;16(2 Suppl):SE261–318. Review.PubMedGoogle Scholar
  2. 2.
    Horlocker TT, Wedel DJ, Rowlingson JC, Enneking FK, et al. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition). Reg Anesth Pain Med. 2017;35(1):64–101.CrossRefGoogle Scholar
  3. 3.
    Manchikanti L, Abdi S, Atluri S, Benyamin RM, et al. An update of comprehensive evidence based guidelines for interventional techniques in chronic spinal pain. Part II: guidance and recommendations. Pain Physician. 2013;16(2 Suppl):S49–283.PubMedGoogle Scholar
  4. 4.
    Meisenberg G, Simmons WH. Principles of medical biochemistry. Philadelphia: Elsevier/Mosby; 2012.Google Scholar
  5. 5.
    Rapaport SI, Rao LV. The tissue factor pathway: how it has become a “prima ballerina”. Thromb Haemost. 1995;74(1):7–17.PubMedGoogle Scholar
  6. 6.
    Ellison N. Diagnosis and management of bleeding disorders. Anesthesiology. 1977;47(2):171–80.PubMedCrossRefGoogle Scholar
  7. 7.
    Mannucci PM, Federici AB. Management of inherited von Willebrand disease. Best Pract Res Clin Haematol. 2001;14(2):455–62.PubMedCrossRefGoogle Scholar
  8. 8.
    Mannucci PM, Tuddenham EGD. The hemophilias—from royal genes to gene therapy. N Engl J Med. 2001;344(23):1773–9.PubMedCrossRefGoogle Scholar
  9. 9.
    Sallah S, Bobzien W. Bleeding problems in patients with liver disease. Ways to manage the many hepatic effects on coagulation. Postgrad Med. 1999;106(4):187–90, 193–5.PubMedCrossRefGoogle Scholar
  10. 10.
    Weigert AL, Schafer AI. Uremic bleeding: pathogenesis and therapy. Am J Med Sci. 1998;316(2):94–104.PubMedGoogle Scholar
  11. 11.
    Horlocker TT, Wedel DJ, Schroeder DR, Rose SH, Elliott BA, McGregor DG, Wong GY. Preoperative antiplatelet therapy does not increase the risk of spinal hematoma associated with regional anesthesia. Anesth Analg. 1995;80(2):303–9.PubMedGoogle Scholar
  12. 12.
    Cronberg S, Wallmark E, Söderberg I. Effect on platelet aggregation of oral administration of 10 non-steroidal analgesics to humans. Scand J Haematol. 1984;33(2):155–9.PubMedCrossRefGoogle Scholar
  13. 13.
    CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet (London, England). 1996;348(9038):1329–39.CrossRefGoogle Scholar
  14. 14.
    Tam NLK, Pac-Soo C, Pretorius PM. Epidural haematoma after a combined spinal–epidural anaesthetic in a patient treated with clopidogrel and dalteparin. Br J Anaesth. 2006;96:262–5.PubMedCrossRefGoogle Scholar
  15. 15.
    Doktorova M, Motovska Z. Clinical review: bleeding—a notable complication of treatment in patients with acute coronary syndromes: incidence, predictors, classification, impact on prognosis, and management. Crit Care. 2013;17(5):239.PubMedPubMedCentralCrossRefGoogle Scholar
  16. 16.
    O’Neill WW, Serruys P, Knudtson M, van Es GA, et al. Long-term treatment with a platelet glycoprotein-receptor antagonist after percutaneous coronary revascularization. EXCITE Trial Investigators. Evaluation of Oral Xemilofiban in Controlling Thrombotic Events. N Engl J Med. 2000;342(18):1316–24.PubMedCrossRefGoogle Scholar
  17. 17.
    Xi M, Béguin S, Hemker HC. The relative importance of the factors II, VII, IX and X for the prothrombinase activity in plasma of orally anticoagulated patients. Thromb Haemost. 1989;62(2):788–91.PubMedGoogle Scholar
  18. 18.
    Hirsh J, Raschke R, Warkentin TE, Dalen JE, Deykin D, Poller L. Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Chest. 1995;108(4 Suppl):258S–75S.PubMedCrossRefGoogle Scholar
  19. 19.
    Kaye AD, Clarke RC, Sabar R, Vig S, Dhawan KP, Hofbauer R, Kaye AM. Herbal medicines: current trends in anesthesiology practice—a hospital survey. J Clin Anesth. 2000;12(6):468–71.PubMedCrossRefGoogle Scholar
  20. 20.
    Opatrny L, Delaney JA, Suissa S. Gastro-intestinal haemorrhage risks of selective serotonin receptor antagonist therapy: a new look. Br J Clin Pharmacol. 2008;66(1):76–81.PubMedPubMedCentralCrossRefGoogle Scholar
  21. 21.
    Di Nisio M, Middeldorp S, Büller HR. Direct thrombin inhibitors. N Engl J Med. 2005;353(10):1028–40.PubMedCrossRefGoogle Scholar
  22. 22.
    Pollack CV, Reilly PA, Eikelboom J, Glund S, et al. Idarucizumab for dabigatran reversal. N Engl J Med. 2015;373(6):511–20.PubMedCrossRefGoogle Scholar
  23. 23.
    Martin K, Beyer-Westendorf J, Davidson BL, Huisman MV, Sandset PM, Moll S. Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH. J Thromb Haemost. 2016;14(6):1308–13.PubMedPubMedCentralCrossRefGoogle Scholar
  24. 24.
    Moen V, Dahlgren N, Irestedt L. Severe neurological complications after central neuraxial blockades in Sweden 1990-1999. Anesthesiology. 2004;101(4):950–9.PubMedCrossRefGoogle Scholar
  25. 25.
    Ruppen W, Derry S, McQuay H, Moore RA. Incidence of epidural hematoma, infection, and neurologic injury in obstetric patients with epidural analgesia/anesthesia. Anesthesiology. 2006;105(2):394–9.PubMedCrossRefGoogle Scholar
  26. 26.
    Landoni G, Isella F, Greco M, Zangrillo A, Royse CF. Benefits and risks of epidural analgesia in cardiac surgery. Hardman JG, ed. Br J Anaesth. 2015;115(1):25–32.PubMedCrossRefGoogle Scholar
  27. 27.
    Rosero EB, Joshi GP. Nationwide incidence of serious complications of epidural analgesia in the United States. Acta Anaesthesiol Scand. 2016;60(6):810–20.PubMedCrossRefGoogle Scholar
  28. 28.
    Vandermeulen EP, Van Aken H, Vermylen J. Anticoagulants and spinal-epidural anesthesia. Anesth Analg. 1994;79(6):1165–77.PubMedCrossRefGoogle Scholar
  29. 29.
    Christie-Taylor GA, McAuliffe GL. Epidural placement in a patient with undiagnosed acquired haemophilia from factor VIII inhibitor. Anaesthesia. 1999;54(4):367–71.PubMedCrossRefGoogle Scholar
  30. 30.
    Kang SB, Rumball KM, Ettinger RS. Continuous axillary brachial plexus analgesia in a patient with severe hemophilia. J Clin Anesth. 2003;15(1):38–40.PubMedCrossRefGoogle Scholar
  31. 31.
    Stedeford JC, Pittman JAL. Von Willebrand’s disease and neuroaxial anaesthesia. Anaesthesia. 2000;55(12):1228–9.PubMedCrossRefGoogle Scholar
  32. 32.
    Milaskiewicz RM, Holdcroft A, Letsky E. Epidural anaesthesia and Von Willebrand’s disease. Anaesthesia. 1990;45(6):462–4.PubMedCrossRefGoogle Scholar
  33. 33.
    Dunn D, Dhopesh V, Mobini J. Spinal subdural hematoma: a possible hazard of lumbar puncture in an alcoholic. JAMA. 1979;241(16):1712–3.PubMedCrossRefGoogle Scholar
  34. 34.
    Grejda S, Ellis K, Arino P. Paraplegia following spinal anesthesia in a patient with chronic renal failure. Reg Anesth. 1989;14(3):155–7.PubMedGoogle Scholar
  35. 35.
    Levine MN, Raskob G, Beyth RJ, Kearon C, Schulman S. Hemorrhagic complications of anticoagulant treatment. Chest. 2004;126(3):287S–310S.PubMedCrossRefGoogle Scholar
  36. 36.
    Stafford-Smith M. Impaired haemostasis and regional anaesthesia. Can J Anaesth. 1996;43(5 Pt 2):R129–41.PubMedCrossRefGoogle Scholar
  37. 37.
    Benzon HT, McCarthy RJ, Benzon HA, Kendall MC, et al. Determination of residual antiplatelet activity of clopidogrel before neuraxial injections. Br J Anaesth. 2011;107(6):966–71.PubMedCrossRefGoogle Scholar
  38. 38.
    Wille-Jørgensen P, Jørgensen LN, Rasmussen LS. Lumbar regional anaesthesia and prophylactic anticoagulant therapy. Is the combination safe? Anaesthesia. 1991;46(8):623–7.PubMedCrossRefGoogle Scholar
  39. 39.
    Liu SS, Mulroy MF. Neuraxial anesthesia and analgesia in the presence of standard heparin. Reg Anesth Pain Med. 1998;23(6 Suppl 2):157–63.PubMedCrossRefGoogle Scholar
  40. 40.
    Gogarten W, Vandermeulen E, Van Aken H, Kozek S, Llau JV, Samama CM, European Society of Anaesthesiology. Regional anaesthesia and antithrombotic agents: recommendations of the European Society of Anaesthesiology. Eur J Anaesthesiol. 2010;27(12):999–1015.PubMedCrossRefGoogle Scholar
  41. 41.
    Ho AM, Chung DC, Joynt GM. Neuraxial blockade and hematoma in cardiac surgery: estimating the risk of a rare adverse event that has not (yet) occurred. Chest. 2000;117(2):551–5.PubMedCrossRefGoogle Scholar
  42. 42.
    Lumpkin MM. FDA public health advisory. Anesthesiology. 1998;88(2):27A–8A.PubMedCrossRefGoogle Scholar
  43. 43.
    Layton KF, Kallmes DF, Horlocker TT. Recommendations for anticoagulated patients undergoing image-guided spinal procedures. AJNR Am J Neuroradiol. 2006;27(3):468–70.PubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Alan David Kaye
    • 1
  • Thomas Ngo Trang
    • 2
  • Elyse M. Cornett
    • 3
  • Ken Philip EhrhardtJr
    • 4
  • Rinoo Vasant Shah
    • 3
  1. 1.Department of AnesthesiologyLouisiana State University School of MedicineNew OrleansUSA
  2. 2.Department of AnesthesiologyTulane University School of MedicineNew OrleansUSA
  3. 3.Department of AnesthesiologyLouisiana State University Health Sciences Center—ShreveportShreveportUSA
  4. 4.Department of AnesthesiaLouisiana State University Medical CenterNew OrleansUSA

Personalised recommendations